APL-2301
N/A
Report date: 2025/11/12 16:25:14
NME
Base Information
Drug NameAPL-2301
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesAsieris Pharmaceuticals Ltd
China Registration ClassN/A
Develop Information
Active CompaniesAsieris Pharmaceuticals Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A